Healthcare Global Enterprises Ltd. (HCG) has received approval from the Competition Authority of Kenya (CAK) for the proposed acquisition involving the sale of up to 54% of its voting share capital, the company disclosed to stock exchanges on Thursday.
This latest clearance marks a key milestone in the transaction, which involves Aceso Company Pte. Ltd., Hector Asia Holdings II Pte. Ltd., and KIA EBT II Scheme 1 as the acquiring entities. The company had earlier secured a green light from the Competition Commission of India (CCI) on May 2, 2025.
The proposed acquisition was first announced on February 23, 2025, after the Board of Directors approved the execution of a share purchase agreement between the sellers and the aforementioned purchasers. The transaction is expected to bring in strategic investments that could bolster HCG’s oncology-focused healthcare footprint across geographies.
In a regulatory filing under Regulation 30 of SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations, HCG confirmed receipt of the CAK approval on May 7, 2025.
[ad_1]
Source link